Correlation of 68Ga-PSMA-11 PET/CT biodistribution with PSMA expression by immunohistochemistry in patients with HCC: A pilot prospective monocentric study
European Journal of Nuclear Medicine and Molecular Imaging · 2026-11 · 53 (13) · 8582-8596
DOI: 10.1007/s00259-026-08110-y ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 14.09.2026. Verfasst von L Vetrone und 16 weiteren Autor:innen. Beteiligte Einrichtung: Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via G. Massarenti 9, Bologna, 40138, Italy. luigia.vetrone@gmail.com. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Carcinoma, Hepatocellular, Liver Neoplasms, Edetic Acid. Die Arbeit nennt 18 Literaturangaben.
Abstract (Originalsprache)
Purpose
Hepatocellular carcinoma (HCC) is a heterogeneous malignancy with limited diagnostic and prognostic tools beyond conventional imaging modalities such as CT and ceMRI. Prostate-specific membrane antigen (PSMA) expression, observed in the neoangiogenic endothelial cells of HCC, has emerged as a potential target. This study evaluated the correlation between PSMA biodistribution using [^68Ga]Ga-PSMA-11 positron emission tomography (PSMA PET/CT) and PSMA expression by immunohistochemistry (IHC) in surgical HCC patients. Secondary aim was to assess the diagnostic performance of PSMA PET/CT in this prospective cohort.
Methods
This prospective monocentric study enrolled patients with suspected HCC undergoing curative-intent liver resection or transplantation. All participants underwent ceMRI and [^68Ga]Ga-PSMA-11 PET/CT within a 3-month interval, with imaging results correlated to postoperative histopathology and IHC for PSMA expression. Semi-quantitative PET parameters were analyzed alongside tumor grade, vascular invasion, and IHC metrics.
Results
Eligible patients were 39, of those 31 were treated surgically. 27/31 (87%) showed PSMA uptake on PET/CT, with a median SUVmax of 12.6 (IQR10.2-16.5). According to IHC intensity analysis, PSMA was expressed in 22/24 (91.6%) of HCC. High PSMA uptake correlated with strong PSMA expression in tumor-associated vasculature ( p = 0.028). No significant correlations were found between PET parameters and histological features, such as Edmondson grade or vascular invasion ( p > 0.05).
Conclusions
PSMA PET/CT offers robust diagnostic accuracy for HCC and correlates with vascular PSMA expression, suggesting potential utility in preoperative staging. These findings support the further exploration of PSMA imaging as a biomarker for HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via G. Massarenti 9, Bologna, 40138, Italy. luigia.vetrone@gmail.com.
- Department of Hepatobiliary Surgery and Liver Transplant, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
- Pathology Unit, Santa Maria delle Croci Ravenna Hospital, Ravenna, Italy.
- Pathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
- Department of Medical and Surgical Sciences (DIMEC), Bologna University, Bologna, Italy.
- Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via G. Massarenti 9, Bologna, 40138, Italy.
Zitieren
APA
Vetrone, L., Prosperi, E., Prosperi, E., Vasuri, F., Degiovanni, A., Allegri, V., Castellucci, P., Zanoni, L., Nanni, C., Renzulli, M., Lucidi, V., Cattabriga, A., Malizia, C., Ravaioli, M., Cescon, M., Fanti, S., & Farolfi, A. (2026). Correlation of 68Ga-PSMA-11 PET/CT biodistribution with PSMA expression by immunohistochemistry in patients with HCC: A pilot prospective monocentric study. European Journal of Nuclear Medicine and Molecular Imaging, 53(13), 8582-8596. https://doi.org/10.1007/s00259-026-08110-y
Vancouver
Vetrone L, Prosperi E, Prosperi E, Vasuri F, Degiovanni A, Allegri V, et al. Correlation of 68Ga-PSMA-11 PET/CT biodistribution with PSMA expression by immunohistochemistry in patients with HCC: A pilot prospective monocentric study. European Journal of Nuclear Medicine and Molecular Imaging. 2026;53(13):8582-8596. doi:10.1007/s00259-026-08110-y
BibTeX
@article{Vetrone2026,
author = {Vetrone, L and Prosperi, E and Prosperi, E and Vasuri, F and Degiovanni, A and Allegri, V and Castellucci, P and Zanoni, L and Nanni, Cristina and Renzulli, M and Lucidi, V and Cattabriga, A and Malizia, C and Ravaioli, M and Cescon, M and Fanti, S and Farolfi, A},
title = {Correlation of 68Ga-PSMA-11 PET/CT biodistribution with PSMA expression by immunohistochemistry in patients with HCC: A pilot prospective monocentric study},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2026},
volume = {53},
number = {13},
pages = {8582--8596},
doi = {10.1007/s00259-026-08110-y}
}
EUVIMED